Vertex Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

22.02.22	Form 4 875320 (RSS)
09.02.22	Form S-3ASR 875320 (RSS)
03.02.22	Form 4 875320 (RSS)
26.01.22	Vertex Pharmaceuticals Inc. Q4 Profit Increases, beats estimates (RTTNews)
26.01.22	Form 8-K 875320 (RSS)
19.01.22	Form 4 875320 (RSS)
11.01.22	EC Approves Kaftrio In Combination With Ivacaftor To Treat Cystic Fibrosis In Children (RTTNews)
11.01.22	Vertex Pharma: EU Oks KAFTRIO In Combination With Ivacaftor To Treat Children With Cystic Fibrosis (RTTNews)
09.12.21	Direxion Launches mRNA ETF (MSGR) (PR Newswire)
01.12.21	Vertex Pharma Reports Positive Results From Phase 2 Study Of VX-147 - Quick Facts (RTTNews)
19.11.21	Vertex Pharma: Spanish Government Approves Terms For Reimbursement Of KAFTRIO (RTTNews)
12.11.21	Vertex Pharma: CHMP Adopts Positive Opinion For Label Extension Of KAFTRIO To Include 6-11 Age Group (RTTNews)
02.11.21	Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
18.10.21	Vertex Announces Positive Data In Phase 1/2 Trial Dosed With VX-880 For Type 1 Diabetes Treatment (RTTNews)
30.07.21	Vertex Pharmaceuticals Lifts FY21 Revenue Outlook (RTTNews)
29.07.21	Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
28.07.21	Vertex To Initiate Phase 3 Program For Once-Daily Triple Combination Regimen In Cystic Fibrosis (RTTNews)
18.06.21	Santé Canada accorde une Autorisation de mise en marché pour TRIKAFTAMD (élexacaftor/tézacaftor/ivacaftor et ivacaftor) chez les personnes âgées de 12 ans et plus qui présentent au moins une mutat... (PR Newswire)
18.06.21	Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation (PR Newswire)
18.06.21	Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation (PR Newswire)
11.06.21	Stock Alert: Vertex Pharmaceuticals Down On Dropping Plans To Advance VX-864 Study Into Late Stage (RTTNews)
09.06.21	FDA Approves Expanded Use Of Vertex Pharma's Cystic Fibrosis Drug In Younger Patients (RTTNews)
09.06.21	FDA Oks Vertex's Trikafta In Children With CF Ages 6 Through 11 With Certain Mutations (RTTNews)
29.04.21	Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
22.04.21	Vertex Pharma, Obsidian Announce Research Collaboration And Licensing Agreement (RTTNews)
10.03.21	Vertex Reports FDA Fast Track Designation For VX-880 - Quick Facts (RTTNews)
01.02.21	Vertex Pharmaceuticals Inc. Q4 adjusted earnings Miss Estimates (RTTNews)
28.12.20	Vertex's TRIKAFTA Accepted For Priority Review By Canada For Treatment Of Cystic Fibrosis (RTTNews)
22.12.20	Skyhawk, Vertex Enter Into Research Collaboration On Serious Diseases (RTTNews)
30.11.20	Biotech Stocks Facing FDA Decision In December 2020 (RTTNews)
27.11.20	Vertex: EU Approves SYMKEVI With KALYDECO For 6-11 Years Children With Cystic Fibrosis (RTTNews)
05.11.20	Vertex: European Commission Approves KALYDECO To Treat Infants With Cystic Fibrosis (RTTNews)
05.11.20	BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch (RTTNews)
29.10.20	Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
15.10.20	Stock Alert: Vertex Pharma Tanks 15% On Stopping Development Of Protein-deficiency Drug (RTTNews)
15.10.20	FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade (RTTNews)
14.09.20	Vertex Announces EMA Type II Variation Marketing Authorization Application Validation For KAFTRIO (RTTNews)
02.09.20	ATNX To Face FDA In Feb, ICPT Trims Workforce, JNCE Jumps On GILD Deal, SNY's Kevzara Flops Again (RTTNews)
21.08.20	Vertex : EU Approves KAFTRIO-Ivacaftor To Treat Cystic Fibrosis In People Ages 12 Years And Older (RTTNews)
31.07.20	PRPO Up 400% As It Readies For Rollout Of COVID-19 Test, LXRX Realigns Business, VRTX Boosts Outlook (RTTNews)
30.07.20	Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
30.06.20	Vertex Pharma: NHS England To Expand Reimbursement Agreement To Include KAFTRIO (RTTNews)
26.06.20	Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF (RTTNews)
01.05.20	Vertex: KALYDECO Gets European CHMP Positive Opinion For CF In Children (RTTNews)
29.04.20	Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
27.03.20	Vertex Pharma Confirms 2020 Business Outlook, Supply Chain Continuity (RTTNews)
09.03.20	Vertex Pharma Says No Coronavirus Impact On Supply Chain Or 2020 Outlook (RTTNews)
19.02.20	Stock Alert: VRTX Trading Close To 52-Week High (RTTNews)
31.01.20	Vertex Pharma (VRTX) Q4 Results Trounce Estimates, Sees Stronger 2020 (RTTNews)
30.01.20	Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

22:34		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
17:58		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
17:58		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
17:58		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
17:56		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
16:06		Bayer-Aktie in Rot: FDA erweitert Zulassung für Bayer-Krebsmedikament Nubeqa
15:58		Anleger in Frankfurt halten sich zurück: LUS-DAX liegt nachmittags im Minus
15:58		Donnerstagshandel in Europa: Euro STOXX 50 zeigt sich nachmittags schwächer

22:34

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

17:58

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

17:58

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

17:58

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone

17:56

Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an

16:06

Bayer-Aktie in Rot: FDA erweitert Zulassung für Bayer-Krebsmedikament Nubeqa